We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $10.9B
1-Year Est. Return 70.31%
This Fund
S&P 500
This Quarter Est. Return
+4.71%
1 Year Est. Return
+70.31%
3 Year Est. Return
+250.68%
5 Year Est. Return
+304.91%
10 Year Est. Return
AUM
$9.44B
AUM Growth
+$1.08B
Cap. Flow
-$287M
Cap. Flow %
-3.05%
Top 10 Hldgs %
56.7%
Holding
92
New
16
Increased
26
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$112M
2
ZM icon
Zoom
ZM
+$83.8M
3
GIL icon
Gildan
GIL
+$73.7M
4
EPC icon
Edgewell Personal Care
EPC
+$60.3M
5
AMCR icon
Amcor
AMCR
+$56.1M

Top Sells

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$298M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$196M
3
FLR icon
Fluor
FLR
+$164M
4
ROIV icon
Roivant Sciences
ROIV
+$103M
5
VST icon
Vistra
VST
+$80.9M

Sector Composition

Rank Sector Weight
1 Healthcare 27.66%
2 Utilities 19.69%
3 Miscellaneous 13.55%
4 Industrials 9.76%
5 Energy 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$81.9B
$1.28B 13.53%
+5,150,000
New +$1.33B
TLN
2
Talen Energy Corp
TLN
$14.6B
$1.15B 12.18%
3,602,171
FTAI icon
3
FTAI Aviation
FTAI
$20.5B
$631M 6.69%
2,576,186
-1,123,814
-30% -$298M
GLNG icon
4
Golar LNG
GLNG
$5.26B
$497M 5.26%
9,178,978
TEVA icon
5
Teva Pharmaceuticals
TEVA
$43.8B
$459M 4.87%
15,250,000
-6,105,510
-29% -$196M
VTRS icon
6
Viatris
VTRS
$19.4B
$453M 4.79%
33,500,000
+8,000,000
+31% +$112M
TAC icon
7
TransAlta
TAC
$3.95B
$233M 2.47%
17,781,325
BGC icon
8
BGC Group
BGC
$5.75B
$228M 2.41%
23,300,000
+2,300,000
+11% +$21.3M
VST icon
9
Vistra
VST
$46.9B
$225M 2.39%
1,500,000
-500,000
-25% -$80.9M
CEG icon
10
Constellation Energy
CEG
$100B
$200M 2.12%
715,000
+45,000
+7% +$13.7M
ARQT icon
11
Arcutis Biotherapeutics
ARQT
$3.13B
$195M 2.06%
8,271,577
MCY icon
12
Mercury Insurance
MCY
$5.69B
$190M 2.01%
2,154,504
+100,000
+5% +$8.94M
KNSA icon
13
Kiniksa Pharmaceuticals
KNSA
$6.23B
$181M 1.91%
3,750,000
+421,347
+13% +$18.7M
ZYME icon
14
Zymeworks
ZYME
$2.07B
$175M 1.86%
7,000,000
+1,250,000
+22% +$29.6M
AKAM icon
15
Akamai
AKAM
$16B
$149M 1.58%
1,300,000
+100,000
+8% +$10M
LBTYA icon
16
Liberty Global Class A
LBTYA
$3.6B
$142M 1.51%
11,752,855
+1,734,423
+17% +$20.2M
ROIV icon
17
Roivant Sciences
ROIV
$27.1B
$139M 1.47%
5,000,000
-4,000,000
-44% -$103M
AMRX icon
18
Amneal Pharmaceuticals
AMRX
$6.27B
$137M 1.45%
11,037,589
-1,297,352
-11% -$17.4M
LILAK icon
19
Liberty Latin America Class C
LILAK
$1.62B
$136M 1.44%
16,934,973
+5,212,344
+44% +$37.2M
DK icon
20
Delek US
DK
$4.3B
$121M 1.28%
2,687,449
CMPR icon
21
Cimpress
CMPR
$2.17B
$119M 1.26%
1,629,419
+104,419
+7% +$7.72M
ECVT icon
22
Ecovyst
ECVT
$1.11B
$117M 1.24%
9,136,067
-1,363,933
-13% -$15.4M
LBTYK icon
23
Liberty Global Class C
LBTYK
$3.51B
$109M 1.15%
9,259,361
+3,137,779
+51% +$36M
ADEA icon
24
Adeia
ADEA
$2.89B
$103M 1.09%
4,284,205
EPC icon
25
Edgewell Personal Care
EPC
$1.32B
$85.4M 0.9%
4,000,000
+2,992,929
+297% +$60.3M

Similar funds

Rubric Capital Management (New York)'s Q1 2026 Portfolio in Review

As of Q1 2026, Rubric Capital Management (New York) held 92 positions worth $9.44B, up 13% from $8.36B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Rubric Capital Management (New York) withdrew a net $287M in Q1 2026, closing 9 positions and reducing 14 holdings. Its most notable exit was Fluor, an estimated $164M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 33% a quarter earlier, followed by Utilities and Miscellaneous.

Against the trend, Rubric Capital Management (New York) opened a new position in Zoom worth $80.5M.

  • Rubric Capital Management (New York)'s largest Q1 2026 buy was Zoom: 1,001,006 shares worth $80.5M.
  • Rubric Capital Management (New York) added most to Viatris in Q1 2026, an estimated $112M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $298M.
  • Rubric Capital Management (New York) fully exited Fluor in Q1 2026, selling an estimated $164M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 57% of its $9.44B portfolio in Q1 2026.
  • Rubric Capital Management (New York) opened 16 new positions and closed 9 in Q1 2026.
  • Rubric Capital Management (New York)'s portfolio value rose 13% quarter-over-quarter to $9.44B.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2026, filed 15 May 2026.